Sanofi/GSK B.1.351 adjuvanted vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sanofi/GSK B.1.351 adjuvanted vaccine, covering 2023-07-03 to 2023-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults [Phase 3]